Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.

Brain pathology (Zurich, Switzerland) - 1 May 2021

Preusse Corinna, Eede Pascale, Heinzeling Lucie, Freitag Kiara, Koll Randi, Froehlich Waltraud, Schneider Udo, Allenbach Yves, Benveniste Olivier, Schänzer Anne, Goebel Hans-Hilmar, Stenzel Werner, Radke Josefine

Abstract excerpt

Dermatomyositis (DM) is a systemic idiopathic inflammatory disease affecting skeletal muscle and skin, clinically characterized by symmetrical proximal muscle weakness and typical skin lesions. Recently, myositis-specific autoantibodies (MSA) became of utmost importance because they strongly correlate with distinct clinical manifestations and prognosis. Antibodies against transcription intermediary factor 1γ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation

Share to Neoplasms

Share to Phenotype

Share to Prognosis

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 34043263
DOI: 10.1111/bpa.12957
PMCID: PMC8412076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.PMID 34043263Read ↗

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositisSemantic proximity Read ↗

Identification of distinctive interferon gene signatures in different types of myositisSemantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

Distinct interferon signatures stratify inflammatory and dysimmune myopathiesSemantic proximity Read ↗

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.Semantic proximity Read ↗

The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in DermatomyositisSemantic proximity Read ↗

Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation–associated gene 5 dermatomyositisSemantic proximity Read ↗

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon SystemSemantic proximity Read ↗

Multi-modal single-cell sequencing identifies cellular immunophenotypes associated with juvenile dermatomyositis disease activitySemantic proximity Read ↗

Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory MyopathySemantic proximity Read ↗

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.Semantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.